Hong S J, Chang C C
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan 100.
J Neurophysiol. 1998 Nov;80(5):2550-8. doi: 10.1152/jn.1998.80.5.2550.
This study aims to evaluate whether endogenous ATP or adenosine modulates the neurotransmission and contractile function of mouse phrenic nerve-diaphragm. Bath application of ATP (1 mM) and alpha, beta-methylene ATP (m-ATP, 0.1 mM) elevated muscle tones, depressed contractions (approximately 12%), and depolarized muscle membranes (approximately 20 mV). Adenosine (1 mM) or low concentrations of ATP (0.1 mM) had no effect. In a low Ca2+ media, ATP caused prolonged inhibitions of endplate potentials (EPPs), whereas m-ATP augmented EPPs while both agents produced slight effects in normal Tyrode solution. When applied by puff ejection, ATP and m-ATP additionally elicited fast transient suppressions of EPPs in association with inhibitions of high K+-evoked releases of miniature EPPs. Blockades of P2 purinoceptors with suramin antagonized all the effects of ATP and m-ATP except the prolonged inhibitions of EPPs induced by ATP, which were antagonized instead by 8-cyclopentyl-1,3-dipropylxanthine (CPDPX), an A1 adenosine receptor antagonist. Suramin and CPDPX did not change contractions nor alter EPPs evoked by a low- or high-frequency nerve stimulation. The results indicate that exogenously applied ATP and m-ATP, via activations of distinct pre- and postsynaptic purinoceptors, exert inhibitory and facilitatory pharmacological modulations on the mature neuromuscular junction. However, because of intrinsic high efficiency of the synaptic transmission under physiological conditions, endogenously released ATP and its degradation product-adenosine-do not build up to concentrations high enough to alter motor functions.
本研究旨在评估内源性ATP或腺苷是否调节小鼠膈神经-膈肌的神经传递和收缩功能。浴用ATP(1 mM)和α,β-亚甲基ATP(m-ATP,0.1 mM)可提高肌张力、抑制收缩(约12%)并使肌膜去极化(约20 mV)。腺苷(1 mM)或低浓度ATP(0.1 mM)则无此作用。在低钙培养基中,ATP可导致终板电位(EPPs)的长时间抑制,而m-ATP可增强EPPs,同时这两种药物在正常台氏液中均产生轻微影响。当通过喷雾喷射给药时,ATP和m-ATP还会引起EPPs的快速短暂抑制,并伴有对高钾诱发的微小EPPs释放的抑制。用苏拉明阻断P2嘌呤受体可拮抗ATP和m-ATP的所有作用,但ATP诱导的EPPs的长时间抑制除外,后者可被A1腺苷受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(CPDPX)拮抗。苏拉明和CPDPX不改变收缩,也不改变低频或高频神经刺激诱发的EPPs。结果表明,外源性应用的ATP和m-ATP通过激活不同的突触前和突触后嘌呤受体,对成熟的神经肌肉接头发挥抑制性和促进性药理调节作用。然而,由于生理条件下突触传递的内在高效率,内源性释放的ATP及其降解产物腺苷不会积累到足以改变运动功能的浓度。